OrphanDrug
OrphanDrug
Pharma Knowledge Base

hypertrophic cardiomyopathy 19

ORPHA: 155

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Classification & Codes

Overview

hypertrophic cardiomyopathy that has material basis in heterozygous mutation in the calreticulin gene (CALR3) on chromosome 19p13.11

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Classification & Codes

Orphanet Code

ORPHA:155
hypertrophic cardiomyopathy 19
OrphanetORPHA:155
Treatments0 drug(s)
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO